jain.com

$55M equity rights offering

Company: Core Scientific

Subject kind
financing
Statement date
2023-12-03
Promised by
2024-01-05
Promised amount
55000000.0 USD
Current status
verified

What the later record shows

Delivered late

The up-to-$55 million equity rights offering was consummated on the Effective Date. That date fell after the January 5, 2024 target because the plan was only confirmed on January 16, 2024. The exact date is not stated.

“on January 16, 2024, the Bankruptcy Court entered an order confirming the Plan of Reorganization (the “Confirmation Order”)”
2024-03-12 · Core Scientific 10-K filed 2024-03-13 View cached copy (2026-08-31)Live source ↗
“the Company commenced an equity rights offering in accordance therewith on November 20, 2023, which was consummated on the Effective Date”
2024-05-05 · Core Scientific 424B3 filed 2024-05-06 View cached copy (2026-08-31)Live source ↗

Checked November 16, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.

The claim, verbatim

A $55 million equity rights offering, anticipated at $0.34 per share, is to provide liquidity upon emergence.

Source (primary)

core-scientific 8-K exhibit (d31518dex991.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-15)Live source ↗

Quote: “$55 million equity rights offering and $80 million exit facility (of which $40 million is new money) provide liquidity upon emergence”

How we checked this

Attempted on November 17, 2026. We could not read enough of the cited source to check this claim.

The verification run did not return a result for this claim (claude -p exit 1: b'').

What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312523288040/d31518dex991.htm) in full (52,558 characters, retrieved November 15, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms core-scientific 8-K exhibit (d31518dex991.htm)

Quote: “$55 million equity rights offering and $80 million exit facility (of which $40 million is new money) provide liquidity upon emergence”

View cached copy (2026-11-15)Live source ↗

confirms Core Scientific 10-K filed 2024-03-13

Quote: “on January 16, 2024, the Bankruptcy Court entered an order confirming the Plan of Reorganization (the “Confirmation Order”)”

View cached copy (2026-08-31)Live source ↗

confirms Core Scientific 424B3 filed 2024-05-06

Quote: “the Company commenced an equity rights offering in accordance therewith on November 20, 2023, which was consummated on the Effective Date”

View cached copy (2026-08-31)Live source ↗

Record of changes

November 16, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
November 16, 2026 — outcome unconfirmed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
November 16, 2026 — verified
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.